LIN28B Antibody (Center) Blocking Peptide

LIN28B Antibody (Center) Blocking Peptide

€363.00
In stock
SKU
AC-BP1485c
Catalog Number: AC-BP1485c
Size: 500 µg
Datasheet
Request Information
Background:
Lin-28 homolog B (LIN28B) is overexpressed in hepatocellular carcinoma. The heterochronic gene lin-28 is a key regulator of developmental timing in the nematode Caenorhabditis elegans. Similar with lin-28 proteins, LIN28B conserves a cold shock domain and a pair of CCHC zinc finger domains. Phylogenetic analysis suggests that they might arise as a result of duplication from an ancestral gene. Overexpression of LIN28B was noted in most HCC cell lines and clinical samples. A short LIN28B isoform was also identified in non-tumor liver tissue and fetal liver. Although predominantly localized in the cytoplasm, LIN28B protein shows cell cycle-dependent nuclear translocation in Huh7 cells. Induced expression of exogenous LIN28B in a tet-off cell line promoted cancer cell proliferation.

Other Names:
Protein lin-28 homolog B, Lin-28B, LIN28B, CSDD2

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1485c was selected from the Center region of human LIN28B. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: LIN28B

Gene ID: 389421
Primary Accession: Q6ZN17
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:LIN28B Antibody (Center) Blocking Peptide